Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Exchange Rates
Interest Rates
Futures
Economy
Global Metrics

Bellicum Pharmaceuticals Shares Outstanding 2013-2019 | BLCM

Bellicum Pharmaceuticals shares outstanding from 2013 to 2019. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
  
Bellicum Pharmaceuticals Annual Shares Outstanding
(Millions of Shares)
2018 4
2017 3
2016 3
2015 3
2014 0
2013 0
2012 0
Bellicum Pharmaceuticals Quarterly Shares Outstanding
(Millions of Shares)
Q3 2019 5
Q2 2019 5
Q1 2019 4
Q4 2018 4
Q3 2018 4
Q2 2018 4
Q1 2018 3
Q4 2017 3
Q3 2017 3
Q2 2017 3
Q1 2017 3
Q4 2016 3
Q3 2016 3
Q2 2016 3
Q1 2016 3
Q4 2015 3
Q3 2015 3
Q2 2015 3
Q1 2015 3
Q4 2014 0
Q3 2014 0
Q2 2014 0
Q1 2014 0
Q4 2013
Q4 2012
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.051B $0.001B
Bellicum Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company. It is focused on discovering and developing cellular immunotherapies for various forms of cancer, including both hematological and solid tumors, as well as orphan inherited blood disorders. The Company's lead clinical product candidate is BPX-501, an adjunct T-cell therapy in multiple Phase I/II clinical trials. It is also developing BPX-201, a dendritic cell cancer vaccine, which is in a Phase I clinical trial for the treatment of metastatic castrate-resistant prostate cancer. Bellicum Pharmaceuticals, Inc. is based in Houston, Texas.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $68.224B 39.46
Takeda Pharmaceutical (TAK) Japan $59.662B 10.57
Astellas Pharma (ALPMY) Japan $32.195B 16.08
Eisai (ESALY) Japan $22.957B 44.26
Merck (MKGAF) Germany $17.215B 23.49
Grifols, S.A (GRFS) Spain $17.058B 22.35
Neurocrine Biosciences (NBIX) United States $9.668B 268.59
Ono Pharmaceutical (OPHLF) Japan $9.450B 20.20
Catalent (CTLT) United States $8.682B 35.72
Ionis Pharmaceuticals (IONS) United States $8.661B 17.54
Recordati Industria Chimica E Farmaceutica S.P.A (RCDTF) Italy $8.449B 0.00
Jazz Pharmaceuticals (JAZZ) Ireland $7.741B 9.89
IPSEN SA ADR (IPSEY) France $6.419B 0.00
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $5.877B 0.00
Orion OYJ (ORINY) Finland $5.871B 30.12
STADA ARZNEIMI (STDAF) Germany $5.543B 0.00
Hypermarcas (HYPMY) Brazil $5.269B 16.03
United Therapeutics (UTHR) United States $4.651B 0.00
Evotec AG (EVTCY) Germany $4.226B 68.30
Arrowhead Pharmaceuticals (ARWR) United States $4.122B 76.51
FibroGen (FGEN) United States $3.911B 114.92
Nektar Therapeutics (NKTR) United States $3.879B 0.00
PTC Therapeutics (PTCT) United States $3.597B 0.00
Sage Therapeutics (SAGE) United States $3.555B 0.00
ChemoCentryx (CCXI) United States $2.834B 0.00
Taro Pharmaceutical Industries (TARO) Israel $2.798B 11.32
Aurinia Pharmaceuticals Inc (AUPH) Canada $2.200B 0.00
Pacira Pharmaceuticals (PCRX) United States $2.089B 61.81
Xencor (XNCR) United States $2.035B 61.85
Heron Therapeutics (HRTX) United States $1.903B 0.00
Ironwood Pharmaceuticals (IRWD) United States $1.898B 23.27
Tilray (TLRY) Canada $1.719B 0.00
USANA Health Sciences (USNA) United States $1.570B 16.42
Corcept Therapeutics (CORT) United States $1.563B 18.99
CLINIGEN GP (CLIGF) United Kingdom $1.506B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $1.436B 9.80
Theravance Biopharma (TBPH) Cayman Islands $1.409B 0.00
Endo (ENDP) Ireland $1.349B 2.48
Zogenix (ZGNX) United States $1.327B 0.00
Akebia Therapeutics (AKBA) United States $1.093B 0.00
Enanta Pharmaceuticals (ENTA) United States $1.069B 33.12
Portola Pharmaceuticals (PTLA) United States $1.058B 0.00
Karyopharm Therapeutics (KPTI) United States $1.026B 0.00
Dermira (DERM) United States $1.022B 0.00
Radius Health (RDUS) United States $0.920B 0.00
ImmunoGen (IMGN) United States $0.919B 0.00
Aerie Pharmaceuticals (AERI) United States $0.881B 0.00
Collegium Pharmaceutical (COLL) United States $0.775B 0.00
TherapeuticsMD (TXMD) United States $0.656B 0.00
Flexion Therapeutics (FLXN) United States $0.622B 0.00
Crinetics Pharmaceuticals (CRNX) United States $0.540B 0.00
Molecular Templates (MTEM) United States $0.537B 0.00
Catalyst Pharmaceuticals (CPRX) United States $0.529B 64.13
Ardelyx (ARDX) United States $0.524B 0.00
Translate Bio (TBIO) United States $0.480B 0.00
BioSpecifics Technologies Corp (BSTC) United States $0.476B 20.53
Aptorum Group (APM) Hong Kong, SAR China $0.448B 0.00
Innate Pharma SA (IPHYF) France $0.442B 0.00
Organogenesis Holdings (ORGO) United States $0.436B 0.00
BioCryst Pharmaceuticals (BCRX) United States $0.434B 0.00
Recro Pharma (REPH) United States $0.399B 0.00
Siga Technologies (SIGA) United States $0.391B 8.93
Calithera Biosciences (CALA) United States $0.390B 0.00
DURECT (DRRX) United States $0.385B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.377B 0.00
Harpoon Therapeutics (HARP) United States $0.372B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.367B 0.00
Lannett Co Inc (LCI) United States $0.366B 5.88
Indivior (INVVY) United States $0.360B 2.14
Rafael Holdings (RFL) United States $0.328B 0.00
Concert Pharmaceuticals (CNCE) United States $0.326B 0.00
Spectrum Pharmaceuticals (SPPI) United States $0.314B 0.00
OptiNose (OPTN) United States $0.308B 0.00
Oasmia Pharmaceutical AB (OASMY) Sweden $0.284B 0.00
KalVista Pharmaceuticals (KALV) United States $0.270B 0.00
Foamix Pharmaceuticals (FOMX) Israel $0.268B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.260B 0.00
Ocular Therapeutix (OCUL) United States $0.252B 0.00
MEI Pharma (MEIP) United States $0.244B 0.00
La Jolla Pharmaceutical (LJPC) United States $0.227B 0.00
IMV INC (IMV) Canada $0.220B 0.00
Matinas Biopharma Holdings (MTNB) United States $0.212B 0.00
Nature's Sunshine Products (NATR) United States $0.202B 34.80
Jounce Therapeutics (JNCE) United States $0.193B 2.58
Taiwan Liposome (TLC) Taiwan $0.191B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.130B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.128B 0.00
AcelRx Pharmaceuticals (ACRX) United States $0.124B 0.00
CannTrust Holdings (CTST) Canada $0.120B 0.00
Xeris Pharmaceuticals (XERS) United States $0.117B 0.00
ALLERGY THERAPT (AGYTF) United Kingdom $0.114B 0.00
Otonomy (OTIC) United States $0.111B 0.00
Redhill Biopharma (RDHL) Israel $0.108B 0.00
Aquestive Therapeutics (AQST) United States $0.106B 0.00
ASSERTIO THERAPEUTICS, INC (ASRT) United States $0.104B 0.00
CV Sciences (CVSI) United States $0.090B 0.00
Neos Therapeutics (NEOS) United States $0.085B 0.00
Champions Oncology (CSBR) United States $0.082B 0.00
MediWound (MDWD) Israel $0.081B 0.00
Infinity Pharmaceuticals (INFI) United States $0.078B 0.00
CTI BioPharma (CTIC) United States $0.075B 0.00
Entasis Therapeutics Holdings (ETTX) United States $0.071B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.069B 20.68
Onconova Therapeutics (ONTX) United States $0.069B 0.00
IsoRay (ISR) United States $0.065B 0.00
SCYNEXIS (SCYX) United States $0.062B 0.00
RENEURON GP (RNUGF) United Kingdom $0.059B 0.00
Nivalis Therapeutics (ALPN) United States $0.058B 0.00
AgeX Therapeutics (AGE) United States $0.055B 0.00
Aclaris Therapeutics (ACRS) United States $0.055B 0.00
Opiant Pharmaceuticals (OPNT) United States $0.055B 0.00
VAXART, INC (VXRT) United States $0.052B 0.00
Summit Therapeutics (SMMT) United Kingdom $0.051B 0.00
Natural Alternatives (NAII) United States $0.051B 23.00
Forward Pharma (FWP) Denmark $0.049B 0.00
Dipexium Pharmaceuticals (PLXP) United States $0.048B 0.00
Adamis Pharmaceuticals (ADMP) United States $0.047B 0.00
PolarityTE (PTE) United States $0.043B 0.00
Mannatechorporated (MTEX) United States $0.038B 0.00
Iterum Therapeutics (ITRM) Ireland $0.037B 0.00
Jaguar Animal Health (JAGX) United States $0.035B 0.00
ElectroCore (ECOR) United States $0.033B 0.00
Biomerica (BMRA) United States $0.028B 0.00
Eyegate Pharmaceuticals (EYEG) United States $0.027B 0.00
PharmAthene (ALT) United States $0.026B 0.00
China SXT Pharmaceuticals (SXTC) China $0.024B 0.00
India Globalization Capital (IGC) United States $0.023B 0.00
ProPhase Labs (PRPH) United States $0.021B 0.00
Bio-Path Holdings (BPTH) United States $0.019B 0.00
Regulus Therapeutics (RGLS) United States $0.017B 0.00
Cardiome Pharma (CORV) Canada $0.017B 0.00
Shineco (TYHT) China $0.015B 0.00
NovaBay Pharmaceuticals (NBY) United States $0.015B 0.00
Heat Biologics (HTBX) United States $0.014B 0.00
Vical (BBI) United States $0.014B 0.00
Kitov Pharmaceuticals Holdings (KTOV) Israel $0.014B 0.00
Novan (NOVN) United States $0.013B 0.00
Cyanotech (CYAN) United States $0.013B 0.00
HANCOCK JAFFE (HJLI) United States $0.013B 0.00
Lipocine (LPCN) United States $0.012B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.010B 0.00
Hemispherx BioPharma (AIM) United States $0.009B 0.00
Cytori Therapeutics Inc (PSTV) United States $0.008B 0.00
Tetraphase Pharmaceuticals (TTPH) United States $0.008B 0.00
Xenetic Biosciences (XBIO) United States $0.004B 0.00
Flex Pharma (SLRX) United States $0.004B 0.00
RXi Pharmaceuticals (PHIO) United States $0.002B 0.00
Midatech Pharma (MTP) United Kingdom $0.002B 0.00
Can-Fite Biopharma (CANF) Israel $0.002B 0.00